Mariam Noorulhuda

Datos Biográficos

ID8520191
NOMBREMariam Noorulhuda
NOMBRESMariam
APELLIDONoorulhuda
FIRMANOORULHUDA M
AFILIACIONESNational Institutes of Health
ORCID0000-0002-0724-6316
VERIFICADOSí
TOTAL DE OBRAS4
TOTAL DE CITAS0
TOTAL COMO AUTOR4
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2021
AÑO MÁS RECIENTE DE PUBLICACIÓN2024
ÍNDICE H0

  • How did European countries set health priorities in response to the Covid-19 threat? A comparative document analysis of 24 pandemic preparedness plans across the Euro region

    Open AccessIestyn Williams, Lydia Kapiriri et al.ARTICLEHealth Policy2024

    The COVID-19 pandemic has forced governments across the world to consider how to prioritise the allocation of scarce resources. There are many tools and frameworks that have been designed to assist with the challenges of priority setting in health care. The purpose of this study was to examine the extent to which formal priority setting was evident in the pandemic plans produced by countries in the World Health Organisation's EURO region, during …

  • Stakeholder participation in the Covid-19 pandemic preparedness and response plans

    Open AccessBernardo Aguilera, Razavi s Donya et al.ARTICLEHealth Policy2024

  • Priority setting and equity in Covid-19 pandemic plans

    Open AccessLydia Kapiriri, Suzanne N Kiwanuka et al.ARTICLEHealth Policy and Planning2022

    Priority setting represents an even bigger challenge during public health emergencies than routine times. This is because such emergencies compete with routine programmes for the available health resources, strain health systems and shift health-care attention and resources towards containing the spread of the epidemic and treating those that fall seriously ill. This paper is part of a larger global study, the aim of which is to evaluate the degr…

  • Priority setting during the Covid-19 pandemic

    Open AccessIestyn Williams, Beverley M Essue et al.ARTICLEBMJ Global Health2021

    Development of vaccines is a major breakthrough in the fight against the SARS-CoV-2 virus. Much attention has been paid to how to prioritise between patient groups for vaccination and how to ensure equity, especially in low-income countries, but there are other important decisions that need to be made. These decisions include: (a) choosing between the various vaccines that will become available, (b) continuing to invest in other aspects of the CO…